Kanagawa, Japan

Eiji Honda

USPTO Granted Patents = 15 


 

Average Co-Inventor Count = 6.3

ph-index = 5

Forward Citations = 65(Granted Patents)


Location History:

  • Osaka, JP (2010)
  • Kanagawa, JP (2013 - 2022)

Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Eiji Honda: Innovator in Pharmaceutical Chemistry

Introduction

Eiji Honda is a prominent inventor based in Kanagawa, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 15 patents to his name, he has made remarkable advancements in the field, particularly in the development of compounds that target neurological disorders.

Latest Patents

Among his latest patents is a heterocyclic compound that exhibits an AMPA receptor potentiating action. This compound is represented by a specific formula, as detailed in the patent specifications. It has been identified as a potential prophylactic or therapeutic drug for various conditions, including depression, schizophrenia, Alzheimer's disease, and attention deficit hyperactivity disorder (ADHD). The innovative nature of this compound highlights Honda's commitment to addressing critical health issues through scientific research.

Career Highlights

Eiji Honda has worked with notable companies in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Asahi Kasei Chemicals Corporation. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in drug development.

Collaborations

Some of his notable coworkers include Shinji Nakamura and Masashi Toyofuku, who have also made significant contributions to the field of pharmaceutical chemistry. Their collaborative efforts have further advanced the research and development of innovative compounds.

Conclusion

Eiji Honda's work exemplifies the impact of innovation in the pharmaceutical industry. His patents and collaborations reflect a dedication to improving therapeutic options for patients with neurological disorders. His contributions continue to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…